ABSTRACT. To evaluate the relationship among immune status and increased morbidity and mortality, peripheral blood lymphocytes (CD3 + , CD4 + , CD8 + and CD21 + cells) from 32 healthy dogs over 8 years of age were analyzed. Twenty-five of the 32 dogs were followed-up for 3 years after the analysis; and 14 dogs were found to be diseased, and nine dogs died. There was no notable difference between the ages of the dogs that died compared with the ones that survived. The relative percentage of CD4 + and the CD4 + :CD8 + ratio decreased notably in dogs falling ill compared with healthy dogs. The relative percentage of CD3 + lymphocytes showed a notable decrease in dogs that died within 3 years in comparison with dogs that survived. In a discriminant analysis of morbidity and mortality, most patients were correctly classified as diseased or not and surviving or dead, respectively. These results indicate that the immunophenotypes of peripheral blood lymphocytes in older dogs offer promise as parameters for evaluating mortality and morbidity.
Changes in immune status are considered major contributing factors towards morbidity and mortality in aging humans. Many studies performed in human subjects and in experimental animals have suggested a correlation between immune function and age-related risk of morbidity and mortality. Immunosenescence has been associated with a numerical change in T-cell number [5, 22] . Previous studies suggested that a lower total lymphocyte count was associated with an increased risk of mortality [2, 7, 12] . Similarly, an association of high numbers of CD8 + and low numbers of CD4 + cells or low CD4 + :CD8 + cell ratios with increased mortality has also been demonstrated [1, 3-5, 13, 19, 22] . Additionally, other evidence has been reported on the association of higher mortality with decreased lymphocyte proliferation to mitogens [14, 21] .
Such immunological changes observed in aging humans have also been studied in dogs [9-11, 17, 18] . Our previous study demonstrated age-related changes in lymphocyte subsets (CD3, CD4, CD8, and CD21) in healthy dogs and a notable decrease in the absolute number and relative percentages of lymphocyte subsets in dogs with tumors compared with healthy controls. Furthermore, the relative percentages of particular lymphocyte subsets were significantly decreased in dogs with distant metastatic tumor in comparison with dogs without metastases [20] .
Despite extensive research in humans, few studies evaluating the relationship among age-related change in immune status and higher morbidity and mortality have been performed in dogs. In this study, we analyzed whether the immune status in clinically healthy dogs over 8 years of age that tumor incidence becomes higher [20] could predict future morbidity and mortality.
Peripheral blood was obtained from 32 (11 males and 21 females) dogs over 8 years of age that were evaluated as healthy by physical examination and blood tests at private veterinary hospitals. The blood drawing was conducted between May and June in 2007. None of the animals had chronic diseases or had received any immunosuppressive treatment, including corticosteroids. All blood samples were drawn into ethylenediaminetetraacetic acid (EDTA) tubes and complete blood count (CBC) tests were performed immediately. Retrospective analysis of mortality and morbidity was performed in June 2010, 3 years after the blood sample collection.
Two-color flow cytometry was used to calculate relative percentages of CD3 + (T cells), CD21 + -like (B cells), CD4 + (T-helper cells) and CD8 + (T-cytotoxic cells) cells using canine-specific monoclonal antibodies (mAbs). Details for all mAbs used for flow cytometry assays are listed in Table  1 . Each blood sample was prepared with the protocol that was described in our previous study [20] . Samples were analyzed using a Coulter Epics XL flow cytometer (BeckmanCoulter, Marseille, France) and the Expo32 ADC software (ver. 1.1c; Beckman-Coulter, Marseille, France). Absolute values for each subset were calculated using counts ob-tained from white blood cell (WBC) analysis in combination with flow cytometry data. WBC count was analyzed using a veterinary automatic blood cell calculator (MICROS abc LC-152, Horiba, Tokyo, Japan).
The Kruskal-Wallis rank test with a Dunn's post test and discriminant analysis were used to identify lymphocyte subset patterns that differentiated healthy dogs from dogs that died or became diseased during the follow-up period of 3 years. Analyses were carried out using StatMate III for Windows (Atomusu, Tokyo, Japan). Differences were considered significant where P<0. 05 . All values are presented as means ± SD, medians, or ranges.
Sixteen dogs were alive at the 3-year follow-up; nine of the 25 dogs had died during the 3-year period. Seven were lost to follow-up. Among the dogs that died during the follow-up period, one dog died in the 1st year after blood sample collection, 2 dogs died in the second year, and 6 dogs died in the third year. The causes of death included cancer (n=5), infectious diseases (n=1), cardiovascular diseases (n=1), and unknown causes (n=2). There was no notable difference among the ages of the dogs that died and those that did not. Thirteen of the 25 dogs developed 1 or some diseases during the period after examination. These diseases included cancer (n=5), immune diseases (n=3), neuropathic diseases (n=1), cardiovascular diseases (n=2), disc hernia (n=1), diabetes mellitus (n=1), hepatic disease (n=1) and pyometora (n=1).
To investigate whether lymphocyte subsets correlated with future mortality, dogs were categorized into dogs that survived and those that died ( Table 2) . Of all the lymphocyte subsets analyzed in the present study, only the relative percentage of CD3 + lymphocytes showed any notable decrease in dogs that died in comparison with dogs that survived (P<0.05) ( Table 3 ). The relative percentages of CD4 + , CD8 + and CD21 + lymphocytes and the absolute cell counts of CD21 + lymphocytes were decreased in dead dogs compared with the surviving dogs, but there were no statistical differences.
To investigate whether lymphocyte subsets correlated with future morbidity, dogs were categorized into dogs that remained healthy and those that were diseased (Table 2) , and the lymphocyte subsets were compared ( Table 4 ). The relative percentage of CD4 + lymphocytes demonstrated a significant decrease in dogs with onset of a disease compared with dogs without disease (P<0.01). The relative percentages of CD3 + and CD21 + lymphocytes were decreased in diseased dogs compared with healthy dogs, but there were no statistical differences. On the other hand, the relative percentage of CD8 + lymphocytes was increased in diseased dogs, but there was no statistical difference. The CD4 + :CD8 + ratio notably decreased in dogs with onset of a disease (P<0.05).
White blood cell count, absolute cell counts and relative percentages of all lymphocyte subsets (total lymphocyte, CD3 + , CD4 + , CD8 + and CD21 + ), CD4 + :CD8 + ratio and CD3 + :CD21 + ratio were included in a discriminant analysis to identify the relationship between lymphocyte subsets and increased mortality and morbidity. In a discriminant analysis of mortality, 92.0% of all patients were correctly classified as dead or surviving, as predicted by their immunophenotype. The linear discriminat function was y = -100.6 + 2. . This linear discriminated function estimated dogs to be healthy if y<0 (dependent variable: diseased=10; healthy=-13). The largest coefficient of linear discriminant function to classify dogs as surviving or dead and healthy or diseased was for the CD4 + :CD8 + ratio.
The data presented in the current study suggested that the immunophenotype of peripheral blood lymphocytes in older dogs can be a useful predictor for evaluating immunosenescence, mortality and morbidity in dogs. Age-related immunological changes are mainly represented by alteration in T-cell phenotype and function [15] . Immunosenescence is characterized by alterations in T cell subsets characterized by Table 2 . Continu an increase in CD8 + lymphocytes and CD8 + CD28 − lymphocytes [5, 8] and a decrease in CD4 + :CD8 + lymphocyte ratio in humans [5] . The increase in CD8 + lymphocyte population and an associated decrease in the CD4 + :CD8 + ratio appear to be characteristic of an ageing immune system. This typical effect of aging has been observed in our previous study and other canine studies [6, 10, 11, 20] . In addition, a lower total count of lymphocytes was associated with an increased risk of mortality in older humans [2, 12] . The association of high CD8 + and low CD4 + T cells, or a low CD4 + :CD8 + lymphocyte ratio, with increased mortality was reported in some studies [1-5, 7, 12, 13, 19, 22] . Other studies have reported that the absolute number of CD8 + memory T cells and decreased lymphocyte proliferation to mitogens correlated with increased mortality [14, 16, 21] . Our study demonstrated that the CD4 + :CD8 + ratio significantly decreased in older dogs falling ill compared with dogs that remained healthy within the 3-year follow-up period. These data suggest a relationship between a low CD4 + :CD8 + lymphocyte ratio and higher morbidity in older dogs. In contrast, an association between T-cell subsets and higher mortality was not shown; however, this study may have the following major potential limitations. 1) The number of enrolled dogs was too small to clarify the statistical differences.
2) The cause of mortality was not selected. T-cell subset alterations and immunosenescence should be more relevant for certain conditions, such as mortality from sepsis, meningitis, other infectious diseases or tumors. 3) A follow-up period of 3 years was used to investigate the morbidity and mortality of older dogs, but there are no data as to whether a 3-year follow-up period is suitable to predict mortality and mobility from the lymphocyte subsets of dogs. 4) The immune system comprises various functions and consists of many types of cells, and it is therefore difficult to estimate immune status by one immunological parameter suitable for the assessment of immune functions in healthy dogs and patients suffering from various diseases.
The last limitation, however, may be resolved by the discriminant analysis performed in the current study. The discriminate analysis based upon the WBC count, absolute cell counts, relative percentages of all lymphocyte subsets (total lymphocytes, CD3 + , CD4 + , CD8 + , and CD21 + ), CD4 + :CD8 + ratio and CD3 + :CD21 + ratio identified a relationship between lymphocyte subsets and mortality or morbidity in older dogs. In a discriminant analysis of mortality, 92.0% of the patients were correctly classified by their immunophenotype as survived or dead. Similarly, in a discriminant analysis of morbidity, 100% of the patients were correctly classified as diseased or healthy. However, due to the small population of dogs used in this study, the linear discriminant functions developed here are a temporary. More cases would likely increase the reliability of these discriminant functions, and whether the prognoses of dogs can be estimated should be examined in a prospective study.
The current study suggests that evaluating the peripheral immunophenotype in older dogs may provide a prognostic value of survival perhaps by detecting early indicators of disease not detected by a clinician or owner.
